Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,929.55 +1,398.59 (+2.13%) CMC Crypto 200
1,369.64 -4.20 (-0.31%)
4D Molecular Therapeutics, Inc. (FDMT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 25.64 |
| Open | 25.72 |
| Bid | 25.27 x 100 |
| Ask | 25.37 x 100 |
| Day's range | 24.36 - 25.72 |
| 52-week range | 9.44 - 36.25 |
| Volume | |
| Avg. volume | 632,046 |
| Market cap | 1.31B |
| Beta (5Y monthly) | 2.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Interested To See How 4D Molecular Therapeutics (NASDAQ:FDMT) Uses Its Cash Hoard To Grow
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Simply Wall St.
4D Molecular Therapeutics First Quarter 2024 Earnings: US$0.66 loss per share (vs US$0.88 loss in 1Q 2023)
4D Molecular Therapeutics ( NASDAQ:FDMT ) First Quarter 2024 Results Key Financial Results Revenue: US$28.0k (down 91...
- GuruFocus.com
4D Molecular Therapeutics Inc (FDMT) Q1 2024 Earnings: Misses Analyst Net Income Projections
Comprehensive Analysis of First Quarter Financials and Strategic Developments
© 2024 Yahoo. All rights reserved.